Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhi, Feng ^a,c   Dong, Haifeng ^b   Jia, Xuefeng ^a   Guo, Wenjie ^a   Lu, Huiting ^b   Yang, Yilin ^c   Ju, Huangxian ^a   Zhang, Xueji ^b   Hu, Yiqiao ^a  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; DOXORUBICIN; GRAPHENE OXIDE; MICRORNA 21; MULTIDRUG RESISTANCE PROTEIN 1; NANOCARRIER; POLY(SODIUM 4 STYRENESULFONATE); POLYETHYLENEIMINE; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CAVEOLA; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; ENDOCYTOSIS; GENE EXPRESSION; GENE SILENCING; IN VITRO STUDY; INTERNALIZATION; MULTIDRUG RESISTANCE; NONVIRAL GENE DELIVERY SYSTEM;

BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE SILENCING; GRAPHITE; HUMANS; MCF-7 CELLS; MICRORNAS; POLYETHYLENEIMINE; POLYMERS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SULFONIC ACIDS;

EID: 84875140612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060034     Document Type: Article

References (51)

1. MacDiarmid JA, Amaro-Mugridge NB, Madrid-Weiss J, Sedliarou I, Wetzel S, et al. (2009) Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug. Nat Biotechnol 27: 643-651.
2. Stein WD, Bates SE, Fojo T, (2004) Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack. Curr Drug Targets 5: 333-346.
3. Soma CE, Dubernet C, Bentolila D, Benita S, Couvreur P, (2000) Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials 21: 1-7.
4. Spankuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, et al. (2006) Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo. Cancer Res 66: 5836-5846.
5. Greco F, Vicent MJ, (2009) Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61: 1203-1213.
6. Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, et al. (2011) Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 5: 1483-1494.
7. Xiong XB, Lavasanifar A, (2011) Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin. ACS Nano 5: 5202-5213.
8. Tan B, Piwnica-Worms D, Ratner L, (2000) Multidrug resistance transporters and modulation. Curr Opin Oncol 12: 450-458.
9. Lee CH, (2010) Reversing agents for ATP-binding cassette drug transporters. Methods Mol Biol 596: 325-340.
10. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
11. Zheng T, Wang J, Chen X, Liu L, (2010) Role of microRNA in anticancer drug resistance. Int J Cancer 126: 2-10.
12. Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM, (2011) MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 42: 281-290.
13. Gong C, Yao Y, Wang Y, Liu B, Wu W, et al. (2011) Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137.
14. Mei M, Ren Y, Zhou X, Yuan XB, Han L, et al. (2010) Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat 9: 77-86.
15. Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E, (2009) Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 284: 26533-26546.
16. Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E, (2011) Breast cancer and microRNAs: therapeutic impact. Breast 20Suppl 3: S63-70.
17. Spankuch B, Kurunci-Csacsko E, Kaufmann M, Strebhardt K, (2007) Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene 26: 5793-5807.
18. Jiang J, Yang SJ, Wang JC, Yang LJ, Xu ZZ, et al. (2010) Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. Eur J Pharm Biopharm 76: 170-178.
19. Geim AK, Novoselov KS, (2007) The rise of graphene. Nat Mater 6: 183-191.
20. Sun X, Liu Z, Welsher K, Robinson JT, Goodwin A, et al. (2008) Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res 1: 203-212.
21. Liu Z, Robinson JT, Sun X, Dai H, (2008) PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130: 10876-10877.
22. Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, et al. (2008) High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide. Journal of Physical Chemistry C 112: 17554-17558.
23. Lu CH, Zhu CL, Li J, Liu JJ, Chen X, et al. (2010) Using graphene to protect DNA from cleavage during cellular delivery. Chemical Communications 46: 3116-3118.
24. Kim H, Namgung R, Singha K, Oh IK, Kim WJ, (2011) Graphene Oxide-Polyethylenimine Nanoconstruct as a Gene Delivery Vector and Bioimaging Tool. Bioconjugate Chemistry 22: 2558-2567.
25. Ren T, Li L, Cai X, Dong H, Liu S, et al. (2012) Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery. Polymer Chemistry 3: 2561-2569.
26. Zhang L, Lu Z, Zhao Q, Huang J, Shen H, et al. (2011) Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7: 460-464.
27. Xu Y, Bai H, Lu G, Li C, Shi G, (2008) Flexible Graphene Films via the Filtration of Water-Soluble Noncovalent Functionalized Graphene Sheets. Journal of the American Chemical Society 130: 5856-5857.
28. Shapira A, Livney YD, Broxterman HJ, Assaraf YG, (2011) Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 14: 150-163.
29. Zhang LM, Xia JG, Zhao QH, Liu LW, Zhang ZJ, (2010) Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs. Small 6: 537-544.
30. Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, et al. (2011) Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem Commun (Camb) 47: 5235-5237.
31. Zhou L, Wang W, Tang J, Zhou JH, Jiang HJ, et al. (2011) Graphene Oxide Noncovalent Photosensitizer and Its Anticancer Activity In Vitro. Chemistry - A European Journal 17: 12084-12091.
32. Dong H, Ding L, Yan F, Ji H, Ju H, (2011) The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modified molecular beacon for recognition of microRNA. Biomaterials 32: 3875-3882.
33. Schoof CR, Botelho EL, Izzotti A, Vasques Ldos R, (2012) MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2: 414-433.
34. Ren Y, Kang CS, Yuan XB, Zhou X, Xu P, et al. (2010) Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed 21: 303-314.
35. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, et al. (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 107: 21098-21103.
36. Xia L, Zhang D, Du R, Pan Y, Zhao L, et al. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379.
37. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, et al. (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83: 761-769.
38. Hu CM, Zhang L, (2009) Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab 10: 836-841.
39. Park JS, Yang HN, Jeon SY, Woo DG, Kim MS, et al. (2012) The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis. Biomaterials 33: 8600-8612.
40. Liu P, Yu H, Sun Y, Zhu M, Duan Y, (2012) A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Biomaterials 33: 4403-4412.
41. Kim JH, Yeom JH, Ko JJ, Han MS, Lee K, et al. (2011) Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. J Biotechnol 155: 287-292.
42. Woodcock J, Griffin JP, Behrman RE, (2011) Development of novel combination therapies. N Engl J Med 364: 985-987.
43. Gottesman MM, (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53: 615-627.
44. Li JM, Wang YY, Zhao MX, Tan CP, Li YQ, et al. (2012) Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 33: 2780-2790.
45. Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC, (2012) PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Int J Nanomedicine 7: 4269-4283.
46. Chen BA, Mao PP, Cheng J, Gao F, Xia GH, et al. (2010) Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells. Int J Nanomedicine 5: 437-444.
47. Bae Y, Diezi TA, Zhao A, Kwon GS, (2007) Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J Control Release 122: 324-330.
48. Cao N, Cheng D, Zou S, Ai H, Gao J, et al. (2011) The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 32: 2222-2232.
49. Meng H, Liong M, Xia T, Li Z, Ji Z, et al. (2010) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4: 4539-4550.
50. Hummers WS, Offeman RE, (1958) Preparation of Graphitic Oxide. Journal of the American Chemical Society 80: 1339-1339.
51. Jeong HK, Jin MH, An KH, Lee YH, (2009) Structural Stability and Variable Dielectric Constant in Poly Sodium 4-Styrensulfonate Intercalated Graphite Oxide. The Journal of Physical Chemistry C 113: 13060-13064.